Article: Study finds Memphis, Tenn., is seventh least costly city for biotech firms.

Byline: Maria Burnham

Dec. 24--Compared with major biotechnology hubs like San Francisco, Princeton, N.J., and Philadelphia, Memphis turns out to be a good deal for potential tenants.

But that doesn't necessarily mean companies will be pulling up stakes and rushing to the Mid-South.

In a study of 50 established and up-and-coming biotech cities in North America and Europe, Memphis ranked as the seventh least costly. The study, by the private consultant The Boyd Co., concluded it costs about $8.9 million annually to operate in Memphis.

"Memphis shows very well from an operational cost perspective and that's becoming more and more ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!